Beginning Aug. 14, 2023, new Current Procedural Terminology (CPT®) codes have been created that consolidate over 50 previous codes and greatly streamline the reporting of immunizations for the novel coronavirus (SARS-CoV-2, also known as COVID-19).

Unique CPT codes approved for COVID-19 immunizations

Unique CPT codes approved for COVID-19 immunizations

Beginning on Aug. 14, 2023, the CPT Editorial Panel approved the addition of new product codes 91318-91322 (91318 , 91319 , 91320 , 91321 , 91322) to identify monovalent vaccine product for immunization against COVID-19 (Pfizer, Moderna); retained existing Novavax Product Code 91304 for currently authorized vaccine product available for use in the U.S. and the updated (XBB.1.5) vaccine; deletion and/or revision of all other existing COVID codes (product and administration with associated guidelines and parenthetical note deletions/revisions); and addition of a single administration code (90480) for administration of new (i.e., 91318-91322) and existing (i.e., 91304) COVID-19 vaccine product.

All existing CPT codes that describe COVID-19 vaccine products and associated administration codes that end in “A” for products that are no longer covered under an existing Emergency Use Authorization (EUA) or Biologics License Application (BLA) from the US Food and Drug Administration (FDA) will be deleted effective Nov. 1, 2023.

COVID-19 lab testing & vaccine CPT codes

Access a file with the new CPT codes for testing and vaccine products and vaccine administrations.

Category I vaccine descriptors

Category I vaccine descriptors

To view the updated SARS-CoV-2-related CPT codes approved by the CPT Editorial Panel, please visit the Category I immunizations page.

Find your COVID-19 Vaccine CPT® Codes tool

Find your COVID-19 Vaccine CPT® Codes tool

Effective Nov. 3, 2023, the “Find your COVID-19 vaccine CPT codes” tool will no longer be available because the CPT code structure has been simplified.

Vaccine resources

Vaccine resources

CPT® Assistant provides guidance for new codes

CPT® Assistant provides guidance for new codes

CPT Assistant provides fact sheets for coding guidance for new SARS-CoV-2 (COVID-19)-related vaccine codes.

The fact sheets include:

  • Codes, descriptors and purpose
  • Clinical examples
  • Description of the procedures
  • FAQs

Download the updated August 2023 special edition of the CPT Assistant guide (PDF, includes further information on codes 91318 , 91319 , 91320 , 91321 , 91322)

Download the May 2023 special edition of the CPT Assistant guide (PDF)

Download the March 2023 special edition of the CPT Assistant guide (PDF)

Download the December 2022 special edition of the CPT Assistant guide (PDF)

Download the November 2022 special edition of the CPT Assistant guide (PDF)

Download the October 2022 special edition of the CPT Assistant guide (PDF)

Download the September 2022 special edition of the CPT Assistant guide (PDF)

Download the July 2022 special edition of the CPT Assistant guide (PDF)

Download the June 2­022 special edition of the CPT Assistant guide (PDF)

Download the May 2­022 special edition of the CPT Assistant guide (PDF)

Download the April 2­022 special edition of the CPT Assistant guide (PDF)

Download the March 2022 special edition of the CPT Assistant guide (PDF)

Download the February 2022 special edition of the CPT Assistant guide (PDF)

Download the January 2022 special edition of the CPT Assistant guide (PDF)

Download the November 2021 special edition of the CPT Assistant guide (PDF)

Download the October 2021 special edition of the CPT Assistant guide (PDF)

Download the September 2021 special edition of the CPT Assistant guide (PDF)

Download the May 2021 special edition of the CPT Assistant guide (PDF)

Download the January 2021 special edition of the CPT Assistant guide (PDF)

Download the December 2020 special edition of the CPT Assistant guide (PDF)

Download the November 2020 special edition of the CPT Assistant guide (PDF)

Content Original Link:

https://www.ama-assn.org/practice-management/cpt/covid-19-cpt-vaccine-and-immunization-codes

Access Non-GMO, antigen-free, generic antiviral medication formulas used in Moderna's Spikevax.

VirusTC is a retail provider of concentrated generic antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, Mayo Clinic, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.